Matches in Nanopublications for { ?s ?p "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP875843.RAScJg5pCD29u5GDpa8beW53oJuNmfXMiV33-nGDXZedY130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875843.RAScJg5pCD29u5GDpa8beW53oJuNmfXMiV33-nGDXZedY130_provenance.
- assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP227980.RAGT6pzdUAFL5vLp-R_tqcwuN3Xq8FW8bCWVZJLFk7F1A130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227980.RAGT6pzdUAFL5vLp-R_tqcwuN3Xq8FW8bCWVZJLFk7F1A130_provenance.
- NP767373.RA0bW2xAcEUtEpZ6iwg4ZeS6tbBJTtrLzCVPNwrNYre-c130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767373.RA0bW2xAcEUtEpZ6iwg4ZeS6tbBJTtrLzCVPNwrNYre-c130_provenance.
- NP371681.RARwpq2TFR4TwMKihy4hy8-MsPhZ1FlLye_aHVP99fBZo130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371681.RARwpq2TFR4TwMKihy4hy8-MsPhZ1FlLye_aHVP99fBZo130_provenance.
- NP789854.RAGU_u_DU_htcX1oN-OCxHcIIIANH8gksE8o9dnSpgX2E130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789854.RAGU_u_DU_htcX1oN-OCxHcIIIANH8gksE8o9dnSpgX2E130_provenance.
- NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- NP218537.RAxITV5Ftgz-bZotOzPn-GxKuh9lmF69wz9STPZAMTlEE130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218537.RAxITV5Ftgz-bZotOzPn-GxKuh9lmF69wz9STPZAMTlEE130_provenance.
- NP772130.RADd1R5_L5qb1SogmfEe1MgWcKX6LQqJwprw7nBx0KULU130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772130.RADd1R5_L5qb1SogmfEe1MgWcKX6LQqJwprw7nBx0KULU130_provenance.
- assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP772127.RA47kzLFxfbBNjH7FbVbeR1OYd9O4qtMvRT4cgeyrRnC0130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772127.RA47kzLFxfbBNjH7FbVbeR1OYd9O4qtMvRT4cgeyrRnC0130_provenance.
- NP772128.RAyMRlTwkkJRqb8CgeOn4HTykA2NA_iXLW5zjVeD24SMk130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772128.RAyMRlTwkkJRqb8CgeOn4HTykA2NA_iXLW5zjVeD24SMk130_provenance.
- NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_provenance.
- NP371794.RAgaegw0ygC-JlKjJzfvHxB_fG05qjqtlXT2f3rQzCtB8130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371794.RAgaegw0ygC-JlKjJzfvHxB_fG05qjqtlXT2f3rQzCtB8130_provenance.